Biocept Inc BIOC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:57 PM EDT
1.10quote price arrow up+0.05 (+4.76%)
Volume
116
Close
1.05quote price arrow down-0.03 (-2.78%)
Volume
77,267
52 week range
0.84 - 4.44
Loading...
  • Open1.07
  • Day High1.10
  • Day Low1.03
  • Prev Close1.08
  • 52 Week High4.44
  • 52 Week High Date08/19/21
  • 52 Week Low0.84
  • 52 Week Low Date06/27/22

Key Stats

  • Market Cap17.77M
  • Shares Out16.92M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • YTD % Change-70.99

KEY STATS

  • Open1.07
  • Day High1.10
  • Day Low1.03
  • Prev Close1.08
  • 52 Week High4.44
  • 52 Week High Date08/19/21
  • 52 Week Low0.84
  • 52 Week Low Date06/27/22
  • Market Cap17.77M
  • Shares Out16.92M
  • 10 Day Average Volume0.11M
  • Dividend-
  • Dividend Yield-
  • Beta0.84
  • YTD % Change-70.99

RATIOS/PROFITABILITY

  • EPS (TTM)-0.52
  • P/E (TTM)-2.03
  • Fwd P/E (NTM)-1.79
  • EBITDA (TTM)-6.212M
  • ROE (TTM)-25.68%
  • Revenue (TTM)63.44M
  • Gross Margin (TTM)38.38%
  • Net Margin (TTM)-12.91%
  • Debt To Equity (MRQ)6.05%

EVENTS

  • Earnings Date11/14/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biocept Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Biocept, Inc. is a molecular oncology diagnostics company. The Company focuses on developing and commercializing clinical diagnostic laboratory assays designed to identify tumor cells and cell-free tumor deoxyribonucleic acid (DNA) from blood, and cerebrospinal fluid (CSF). Its product is branded and trademarked under the name of CNSide. In addition to CNSide, its current blood-based testing includes its Target Selector technologies, which enables detection of specific gene...
Samuel Riccitelli
Chairman of the Board, Interim President and Chief Executive Officer
Philippe Marchand Ph.D.
Chief Operating Officer
Antonino Morales CPA
Interim Chief Financial Officer, Director
Antonio Paternostro
Vice President - Sales
Address
9955 Mesa Rim Road
San Diego, CA
92121
United States

Top Peers

SYMBOLLASTCHG%CHG
NH
NantHealth Inc
0.5455+0.0167+3.16%
OTRK
Ontrak Inc
0.7442-0.0263-3.4134%
AUGX
Augmedix Inc
1.72-0.03-1.71%
CSBR
Champions Oncology Inc
9.30-0.12-1.27%
SNCE
Science 37 Holdings Inc
1.76-0.13-6.88%